【摘要】 目的 :观察刺五加注射液联用降纤酶治疗急性脑梗死的临床疗效。方法 :将 86例急性脑梗死患者随机分为 2组 ,治疗组 43例 ,用刺五加注射液 6 0mL加生理盐水 2 5 0mL静滴 ,对照组 43例 ,只用降纤酶治疗。其它治疗 (包括降颅压、降血压、降血糖、抗感染等 ) 2组相同。治疗前后 2组患者均做血液流变学及血脂测定。结果 :2周后治疗组痊愈率为41.86 % ,明显优于对照组的 2 0 .93% (x2 =4.37,P <0 .0 5 ) ,治疗组总有效率为 96 .35 %优于对照组的 91.7% ,但无统计学意义 (P >0 .0 5 )。治疗组对改善血液流变学指标及血脂代谢的作用优于对照组 (P <0 .0 1或P <0 .0 5 )。结论 :刺五加注射液联合降纤酶治疗急性脑梗死疗效优于单用降纤酶更多还原

【Abstract】 Objective:To investigate the effect of ciwujia Injection and Jiangxianmei combination for acute cerebral infarction. Methods:86 patients with cerebral infarction were divided into 2 groups. 43 cases in the treatment group were dripped intravenously with 60ml ciwujia Injection and 250ml physiological saline. 43 cases in the control group were treated only with Jiangxianmei. Both of groups were also treated with other therapeutic method. The hemorheology and blood fat of patients in two groups before and after treatment were determined. Results:The cure rate of the treatment groups in two weeks was 41.86%, which is superior to the control group (20.93%) ( x 2=4.37,P<0.05 ). The total effective rate of the treatment group was 96.35% which is also superior to the control group (91.70%), but there was no statistical difference ( P >0.05). The treatment group was superior to the control group in improving hemorheological index and blood fat metabolism ( P<0.01 or P <0.05). Conclusions: Ciwujia Injection and Jianxianmei combination is superior to Jiangxianme in use alone in clinical effect for acute cerebral infarction.更多还原